Babic Zarko, Jagić Vjekoslav, Petrović Zvonko, Bilić Ante, Dinko Kapetanović, Kubat Goranka, Troskot Rosana, Vukelić Mira
Division of Hepatogastroenterology, Department of Medicine, Sveti Duh General Hospital, Zagreb, Croatia.
World J Gastroenterol. 2003 Mar;9(3):619-21. doi: 10.3748/wjg.v9.i3.619.
To assess the impact of procollagen III peptide as a marker of collagenesis in the development of pseudopolyps in patients with ulcerative colitis.
Development of pseudopolyps was monitored in 25 patients with ulcerative colitis classified according to Powell-Tuck index as mild (n=12) or moderate (n=13) form of disease. Patients with a mild form of disease were treated with oral mesalazine medication (2-4 g/day) and local mesalazine preparation (suppository). Patients with a moderate form of disease received oral mesalazine medication (2-4 g/day), local mesalazine preparation (suppository) and local methylprednisolone at an initial dose of 60 mg/day, followed by dose tapering. How many significant variables (previously determined by analysis of variance) were elevated in the groups with and without pseudopolyp developement was observed. ROC analysis for calculation of new index was made.
Serum values of procollagen III peptide (PIIIP), C-reactive protein (CRP) and C4 complement component (C4) were statistically significantly lower in the group of patients free from pseudopolyp development than those who developed one or more pseudopolyps (0.45+/-0.12 vs 1.42+/-0.70, P<0.0027; 7.6+/-4.7 vs 17.8+/-9.17, P<0.035; and 0.46+/-0.11 vs 0.34+/-0.16, P<0.068, respectively) at endoscopic conrtrols with patohistologically samples during 13 months. There were no statistically significant differences in the values of C3, ceruloplasmin and IgM between the two groups (P>0.05). Discrimination function analysis yielded highest standardized cannon coefficients for PIIIP (0.876), CRP (0.104), C3 (-0.534) and C4 (0.184) (P<0.036). The elevation in two of three laboratory variables (PIIIP, CRP and C4) reached sensitivity of 93 % and specificity of 90 % in the development of pseudopolyps.
It is proposed that an increase in two of the three laboratory parameters (PIIIP, CRP and C4) could improve the accuracy of prediction of the development of pseudopolyps. When using PIIIP, CRP and C4 on decision making, the positive predictive value and accuracy were 90 % and 92 %, respectively.
评估前胶原III肽作为胶原生成标志物在溃疡性结肠炎患者假息肉形成过程中的影响。
对25例溃疡性结肠炎患者的假息肉形成情况进行监测,这些患者根据鲍威尔 - 塔克指数分为轻度(n = 12)或中度(n = 13)疾病形式。轻度疾病患者接受口服美沙拉嗪药物治疗(2 - 4克/天)和局部美沙拉嗪制剂(栓剂)。中度疾病患者接受口服美沙拉嗪药物治疗(2 - 4克/天)、局部美沙拉嗪制剂(栓剂)以及初始剂量为60毫克/天的局部甲基泼尼松龙治疗,随后逐渐减量。观察在有和没有假息肉形成的两组中,有多少显著变量(先前通过方差分析确定)升高。进行ROC分析以计算新指标。
在13个月的内镜检查及病理组织学样本检查中,无假息肉形成的患者组血清前胶原III肽(PIIIP)、C反应蛋白(CRP)和C4补体成分(C4)的值在统计学上显著低于有一个或多个假息肉形成的患者组(分别为0.45±0.12对1.42±0.70,P < 0.0027;7.6±4.7对17.8±9.17,P < 0.035;以及0.46±0.11对0.34±0.16,P < 0.068)。两组之间C3、铜蓝蛋白和IgM的值无统计学显著差异(P > 0.05)。判别函数分析得出PIIIP的标准化典型系数最高(0.876),其次是CRP(0.104)、C3( - 0.534)和C4(0.184)(P < 0.036)。在三个实验室变量(PIIIP、CRP和C4)中,有两个升高时,在假息肉形成过程中的敏感性达到93%,特异性达到90%。
建议三个实验室参数(PIIIP、CRP和C4)中有两个升高可提高假息肉形成预测的准确性。在决策时使用PIIIP、CRP和C4时,阳性预测值和准确性分别为90%和92%。